Cold-hot mismatch between Tc-99m HMPAO-labeled leukocytes and Tc-99m ciprofloxacin in axial skeleton infections: a report of three cases

Clin Nucl Med. 1999 Nov;24(11):855-8. doi: 10.1097/00003072-199911000-00007.

Abstract

Radiolabeled leukocyte scintigraphy is a well-established technique for the diagnosis of inflammation and infection with a typical presentation of a hot spot within the abnormal areas. However, in some cases of osteomyelitis of the axial skeleton, a cold defect pattern has been described. Tc-99m ciprofloxacin is a new agent claimed to be specific for imaging sites containing viable bacteria. In this report, we present three cases of proved bacterial infection of the axial skeleton with a mismatch pattern between Tc-99m ciprofloxin and tagged leukocytes. Although Tc-99m-labeled leukocyte scanning showed a cold defect, probably caused by bone marrow replacement, the Tc-99m ciprofloxacin consecutively revealed a hot spot at the site of infection. These data suggest that Tc-99m ciprofloxacin should be a better agent than radiolabeled leukocytes for detecting osteomyelitis of the axial skeleton.

Publication types

  • Case Reports
  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Infective Agents*
  • Ciprofloxacin*
  • Female
  • Humans
  • Leukocytes
  • Male
  • Middle Aged
  • Osteomyelitis / diagnostic imaging*
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Technetium Tc 99m Exametazime*
  • Technetium*

Substances

  • Anti-Infective Agents
  • Radiopharmaceuticals
  • Technetium Tc 99m Exametazime
  • Ciprofloxacin
  • Technetium